CAS: 865625-56-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ladarixin Sodium REF: TR-L168750CAS: 865625-56-5 | - - - | 5,339.00 € | Fri 10 Jan 25 |
 | Ladarixin sodium REF: 3D-QJB62556CAS: 865625-56-5 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | Ladarixin Sodium REF: TM-T27791CAS: 865625-56-5 | - - - | 167.00 €~1,723.00 € | Mon 03 Feb 25 |
Ladarixin Sodium
Controlled ProductCAS:865625-56-5
Formula:
C11H12F3NO6S2·Na
Color and Shape:
Neat
Molecular weight:
398.33
Ref: TR-L168750
| 100mg | 5,339.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Ladarixin sodium
CAS:865625-56-5
Ladarixin sodium is a synthetic compound that has been shown to have an inhibitory effect …
Formula:
C11H11F3NNaO6S2
Purity:
Min. 95%
Molecular weight:
397.3 g/mol
Ref: 3D-QJB62556
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ladarixin Sodium
CAS:865625-56-5
Ladarixin Sodium, an Chemokine CXCR antagonist, is used potentially for the treatment of type I …
Formula:
C11H12F3NNaO6S2
Color and Shape:
Solid
Molecular weight:
398.32
Ref: TM-T27791
| 2mg | 167.00 € | ||
| 5mg | 271.00 € | ||
| 25mg | 835.00 € | ||
| 50mg | 1,085.00 € | ||
| 100mg | 1,723.00 € | ||
| 1mL*10mM (DMSO) | 270.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
